Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

26.13p
   
  • Change Today:
    -0.13p
  • 52 Week High: 142.50
  • 52 Week Low: 10.25
  • Currency: UK Pounds
  • Shares Issued: 106.84m
  • Volume: 1,753,043
  • Market Cap: £27.91m
  • RiskGrade: 594

Sareum Holdings Overview

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a -9.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a 0.4
Pr/Book 23.8  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Sareum Holdings Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 n/a (1.68) (2.50)p n/a n/a n/a n/a 0.0%
30-Jun-20 0.05 (1.12) (1.50)p n/a n/a n/a n/a 0.0%
30-Jun-21 n/a (1.72) (2.30)p n/a n/a n/a n/a 0.0%
30-Jun-22 n/a 2.58 (3.20)p n/a n/a n/a n/a 0.0%
30-Jun-23 n/a (4.03) (4.70)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Sareum Holdings Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-24 57.00 (5.11) (4.70)p n/a n/a n/a n/a 0.0%
30-Jun-25 n/a n/a (3.60)p n/a n/a n/a n/a 0.0%
30-Jun-26 43.10 n/a 38.00p 0.7 n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Sareum Holdings Company Announcements

Final Issue of RiverFort Subscription Shares 23-Apr-2024 07:00 RNS
Issue of RiverFort Subscription Shares 19-Apr-2024 11:35 RNS
Issue of RiverFort Subscription Shares 15-Apr-2024 15:28 RNS

Sareum Holdings ShareCast News

Sareum allowed European patent for primary kinas... 15-Mar-2024 ShareCast
Sareum reports positive progress in psoriasis pr... 15-Feb-2024 ShareCast
Sareum shares jump on cancer drug licensing deal 02-Jan-2024 ShareCast

Latest Sareum Holdings Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 26.13p
Change Today -0.13p
% Change -0.48 %
52 Week High 142.50
52 Week Low 10.25
Volume 1,753,043
Shares Issued 106.84m
Market Cap £27.91m
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.64% below the market average49.64% below the market average49.64% below the market average49.64% below the market average49.64% below the market average
9.43% below the sector average9.43% below the sector average9.43% below the sector average9.43% below the sector average9.43% below the sector average
Price Trend
94.72% below the market average94.72% below the market average94.72% below the market average94.72% below the market average94.72% below the market average
92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Sareum Holdings Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
13:42 8,402 @ 26.38p
13:22 6,750 @ 26.38p
13:14 4,500 @ 26.21p
12:58 1,000 @ 26.21p
12:51 375 @ 26.21p

Sareum Holdings Key Personnel

CEO Timothy J Mitchell

Top of Page